Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Adeniyi Olagunju

Has grant

Reader in Perinatal Systems Pharmacology

University of Liverpool

United Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United Kingdom

About

Dr. Adeniyi Olagunju is an Assistant Professor at the University of Liverpool in the United Kingdom. His research primarily focuses on pharmacogenetics, particularly the exposure of efavirenz during pregnancy and postpartum, as well as HIV treatment among women. His recent publications include studies on efavirenz resistance in HIV patients and the clinical applications of long-acting anti-infective drugs.

Recent Grants

Grant: Close

Investigating the influence of pregnancy-induced changes in antiretroviral pharmacokinetics together with polymorphisms in drug disposition genes on viral decay dynamics in HIV positive women starting therapy late in pregnancy and postpartum

Open Date: 2017-06-01

Close Date: 2020-05-01

Grant: Close

PhD at the University of Liverpool, UK and clinical research in Nigeria

Open Date: 2012-12-01

Close Date: 2015-10-01

Grant: Close

Master of Research in Biomedical Sciences and Translational Medicine at the University of Liverpool

Open Date: 2011-09-01

Close Date: 2012-09-01

Articles (24)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Dan Hawcutt

Director of Research

University of Liverpool

UNITED KINGDOM

View details

Zachary Stephen

Senior Scientist

University of Washington

UNITED STATES

View details

Catriona Waitt

Professor

University of Liverpool

UNITED KINGDOM

View details

Andrew Owen

University of Liverpool

UNITED KINGDOM

View details

Simone Perazzolo

Sr Scientist

University of Washington

UNITED STATES

View details

Rachel Scott

Associate Professor

Georgetown University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adeniyi Olagunju

Research Interests

Make your next move.

Explore related searches

About

Recent Grants

Articles (24)

The Promises and Prospects of Long-Acting Therapeutics for Treatment and Prevention of Infectious Diseases

Long‐Acting Therapeutics in Pediatric Health: Bridging Innovation and Access

A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Modelling the tail-phase pharmacokinetics of long-acting cabotegravir and rilpivirine from early pregnancy to postpartum at steady state

A Systematic Review of Published Physiologically Based Pharmacokinetic Models for Drug Excretion Into Human Breastmilk: Knowledge Gaps and Opportunities to Optimize Reporting and Modeling Practices

PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing

Bridging the exposure-safety gap in the assessment of fetal exposure to maternal drugs.

Comparative modelling of foetal exposure to maternal long-acting injectable versus oral daily antipsychotics.

Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and Postpartum

Relating CYP2B6 genotype and efavirenz resistance among post-partum women living with HIV with high viremia in Uganda: a nested cross-sectional study

A Holistic Review of the Preclinical Landscape for Long-Acting Anti-infective Drugs Using HIV as a Paradigm

Considerations for the Use of Long-Acting and Extended-Release Agents During Pregnancy and Lactation

Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry

Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry

A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria

Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria.

Validation and Clinical Application of a Liquid Chromatography-Ultraviolet Detection Method to Quantify Dolutegravir in Dried Blood Spots.

Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry

Mechanistic Modeling of Maternal Lymphoid and Fetal Plasma Antiretroviral Exposure During the Third Trimester

Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV.

Collaborators (6)

Dan Hawcutt

Zachary Stephen

Catriona Waitt

Andrew Owen

Simone Perazzolo

Rachel Scott

Make your next move.